Stay updated on mFOLFIRINOX +/- Ramucirumab Clinical Trial
Sign up to get notified when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.

Latest updates to the mFOLFIRINOX +/- Ramucirumab Clinical Trial page
- ChecktodayChange DetectedThe page displays the completed clinical trial record for a randomized Phase II study of mFOLFIRINOX with ramucirumab or placebo, including its eligibility criteria, study locations, outcomes, and supporting documents.SummaryDifference62%

- Check7 days agoChange DetectedThe footer's site revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide NIH announcement says that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov page, which continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, preventing access to the study record and related content. This reflects a site access issue rather than an actual change to the study data.SummaryDifference20%

Stay in the know with updates to mFOLFIRINOX +/- Ramucirumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.